Genome editing and cancer: How far has research moved forward on CRISPR/Cas9?

Ano: 2022

Biomedicine & Pharmacotherapy, 2022, 150, 113011.

Authors: Saikat Mitra, Joyatry Sarker, Anik Mojumder, Tasmim Bintae Shibbir, Rajib Das, Talha Bin Emran, Trina Ekawati Tallei, Firzan Nainu, Asma M. Alshahrani, Kumarappan Chidambaram, Jesus Simal-Gandara.

Autor/a:
Jesús Simal Gándara

Tipo de publicación:
Artigos de impacto